Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors;Matrixmetalloproteinasen als promotoren der tumorinvasion und metastasierung - Eine übersicht unter besonderer berücksichtigung des gastrointestinaltraktes

Zeitschrift fur Gastroenterologie

Volumn 39, Issue 9, 2001, Pages 807-813

  Roeb, E ^a   Matern, S ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Colon carcinom; Invasion; Matrix metalloproteinases; Metastasis; TIMP

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

BASEMENT MEMBRANE; CANCER INVASION; COLON CARCINOMA; DIGESTIVE SYSTEM CANCER; EXTRACELLULAR MATRIX; GASTROINTESTINAL TUMOR; HUMAN; METASTASIS; PROTEIN DEGRADATION; REVIEW; TUMOR GROWTH;

ANIMALS; BASEMENT MEMBRANE; CELL DIVISION; COLORECTAL NEOPLASMS; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 0034804954     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17197     Document Type: Review

References (70)

1. Matrix metalloproteinases in skin
2. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
3. The matrix metalloproteinase family
4. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications
5. Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation
6. Regulation of matrix metalloproteinase expression in tumor invasion
7. Relating matrix metalloproteinase structure to function: Why the 'hemopexin' domain?
8. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
9. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor- and doxycycline
10. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line
11. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
12. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix
13. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth
14. Requirement of specifc proteases in cancer cell intravasation as revealed by novel semiquantitative PCR-based assay
15. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
16. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
17. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
18. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
19. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions
20. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
21. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells
22. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
23. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue
24. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
25. 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma
26. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells
27. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines
28. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells
29. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts
30. Metalloproteinases in tumor progression: The contribution of MMP-9
31. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
32. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
33. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
34. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
35. Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer
36. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer
37. Tissue inhibitors of matrix metalloproteinases in cancer
38. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo
39. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice
40. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells
41. Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasion in vivo
42. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis
43. Prognostic impact of tissue inhibitor of matrix metallproteinase-1 in esophageal carcinoma
44. Sequence of human tissue inhibitor of metalloproteinase and its identity to erythroid-potentiating activity
45. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM102 has erythroid-potentiating activity, suggesting its possible bifunctional role in the hematopoietic microenvironment
46. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
47. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
48. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples
49. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells
50. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
51. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis
52. Unterschiedliche expression von MMP-2, MMP-9 und TIMP-1 bei kolorektalen karzinomen im vergleich zu gesundem darmgewebe
53. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
54. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
55. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells
56. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellularmatrix-dependent pathway
57. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells
58. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells
59. A MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist
60. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
61. Synthetic inhibitors of matrix metalloproteinases
62. Matrix metalloproteinases and their inhibitors in tumour growth and invasion
63. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions
64. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue
65. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells
66. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis
67. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
68. Matrix metalloproteinases: Biologic activity and clinical implications
69. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer
70. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors